CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...

Cantor Fitzgerald upgraded McEwen Mining (MUX) to Buy from Speculative Buy with an unchanged price target of $14.50 after the company completed ...

Kraft Heinz ( KHC) is close to a 52-week low after it reported a 4.6% decline in sales during Q4. Organic sales fell -3.1% ...

Cantor Fitzgerald analyst Deepak Mathivanan maintained a Neutral rating on Zillow Group (NASDAQ:ZG) shares but increased the ...

Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...

Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report ...

The US may use “trade tools” to retaliate against European ESG regulations that affect American companies, said Howard ...

ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga reports.

Fintel reports that on February 11, 2025, Cantor Fitzgerald initiated coverage of Domo (NasdaqGM:DOMO) with a Overweight ...